{
    "medicine_id": "60b87144941243955f1caf8dc156ed64a7cfc04d",
    "platform_id": "DB05039",
    "metadata": {
        "name": "Arcapta Neohaler 75 ug 1 Capsule",
        "composition": "75 ug 1 Indacaterol",
        "clinical_particulars": {
            "therapeutic_indications": "For the long term once daily dosing maintenance of airflow obstruction in patients with chronic obstructive pulmonary disease COPD including chronic bronchitis and or emphysema",
            "contraindications": {
                "disease": "The expected signs and symptoms associated with overdosage of indacaterol are those of excessive beta adrenergic stimulation and occurrence or exaggeration of any of the signs and symptoms e g angina hypertension or hypotension tachycardia with rates up to 200 bpm arrhythmias nervousness headache tremor dry mouth palpitation muscle cramps nausea dizziness fatigue malaise hypokalemia hyperglycemia metabolic acidosis and insomnia As with all inhaled sympathomimetic medications cardiac arrest and even death may be associated with an overdose of indacaterol",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Bronchodilator drugs are the foundation for the treatment of chronic obstructive pulmonary disease The principal inhaled bronchodilator treatments used are \u03b2 2 agonists and anticholinergics either alone or in combination Currently available \u03b2 2 agonists are of either short duration and used multiple times day or of long duration which requires twice daily administration Indacaterol is considered an ultra long acting \u03b2 2 agonist and was recently approved for use in the United States Its duration of action is approximately 24 hours allowing for once daily administration Furthermore this chiral compound it is given as the R enantiomer and acts as a full agonist Cough was the most commonly reported adverse effect with use of indacaterol Compared to salmeterol it has 35 more agonist activity Cough usually occurred within 15 seconds of inhalation of the drug lasted around 6 seconds was not associated with bronchospasm and did not cause discontinuation of the drug Otherwise the drug s safety profile was similar to that of other bronchodilators PMID 22499359",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00408",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Loxapine"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB00177",
                        "description": "Indacaterol may decrease the antihypertensive activities of Valsartan"
                    },
                    {
                        "drugbank-id": "DB00178",
                        "description": "Indacaterol may decrease the antihypertensive activities of Ramipril"
                    },
                    {
                        "drugbank-id": "DB00212",
                        "description": "Indacaterol may decrease the antihypertensive activities of Remikiren"
                    },
                    {
                        "drugbank-id": "DB00275",
                        "description": "Indacaterol may decrease the antihypertensive activities of Olmesartan"
                    },
                    {
                        "drugbank-id": "DB00325",
                        "description": "Indacaterol may decrease the antihypertensive activities of Nitroprusside"
                    },
                    {
                        "drugbank-id": "DB00350",
                        "description": "Indacaterol may decrease the antihypertensive activities of Minoxidil"
                    },
                    {
                        "drugbank-id": "DB00492",
                        "description": "Indacaterol may decrease the antihypertensive activities of Fosinopril"
                    },
                    {
                        "drugbank-id": "DB00519",
                        "description": "Indacaterol may decrease the antihypertensive activities of Trandolapril"
                    },
                    {
                        "drugbank-id": "DB00542",
                        "description": "Indacaterol may decrease the antihypertensive activities of Benazepril"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "Indacaterol may decrease the antihypertensive activities of Cyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00616",
                        "description": "Indacaterol may decrease the antihypertensive activities of Candoxatril"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "Indacaterol may decrease the antihypertensive activities of Mecamylamine"
                    },
                    {
                        "drugbank-id": "DB00722",
                        "description": "Indacaterol may decrease the antihypertensive activities of Lisinopril"
                    },
                    {
                        "drugbank-id": "DB00727",
                        "description": "Indacaterol may decrease the antihypertensive activities of Nitroglycerin"
                    },
                    {
                        "drugbank-id": "DB00765",
                        "description": "Indacaterol may decrease the antihypertensive activities of Metyrosine"
                    },
                    {
                        "drugbank-id": "DB00785",
                        "description": "Indacaterol may decrease the antihypertensive activities of Cryptenamine"
                    },
                    {
                        "drugbank-id": "DB00790",
                        "description": "Indacaterol may decrease the antihypertensive activities of Perindopril"
                    },
                    {
                        "drugbank-id": "DB00800",
                        "description": "Indacaterol may decrease the antihypertensive activities of Fenoldopam"
                    },
                    {
                        "drugbank-id": "DB00876",
                        "description": "Indacaterol may decrease the antihypertensive activities of Eprosartan"
                    },
                    {
                        "drugbank-id": "DB00881",
                        "description": "Indacaterol may decrease the antihypertensive activities of Quinapril"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "Indacaterol may decrease the antihypertensive activities of Methyldopa"
                    },
                    {
                        "drugbank-id": "DB01089",
                        "description": "Indacaterol may decrease the antihypertensive activities of Deserpidine"
                    },
                    {
                        "drugbank-id": "DB01090",
                        "description": "Indacaterol may decrease the antihypertensive activities of Pentolinium"
                    },
                    {
                        "drugbank-id": "DB01116",
                        "description": "Indacaterol may decrease the antihypertensive activities of Trimethaphan"
                    },
                    {
                        "drugbank-id": "DB01119",
                        "description": "Indacaterol may decrease the antihypertensive activities of Diazoxide"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "Indacaterol may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01347",
                        "description": "Indacaterol may decrease the antihypertensive activities of Saprisartan"
                    },
                    {
                        "drugbank-id": "DB01348",
                        "description": "Indacaterol may decrease the antihypertensive activities of Spirapril"
                    },
                    {
                        "drugbank-id": "DB04831",
                        "description": "Indacaterol may decrease the antihypertensive activities of Tienilic acid"
                    },
                    {
                        "drugbank-id": "DB06445",
                        "description": "Indacaterol may decrease the antihypertensive activities of Diethylnorspermine"
                    },
                    {
                        "drugbank-id": "DB07767",
                        "description": "Indacaterol may decrease the antihypertensive activities of Ferulic acid"
                    },
                    {
                        "drugbank-id": "DB08836",
                        "description": "Indacaterol may decrease the antihypertensive activities of Temocapril"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "Indacaterol may decrease the antihypertensive activities of Hexamethonium"
                    },
                    {
                        "drugbank-id": "DB09220",
                        "description": "Indacaterol may decrease the antihypertensive activities of Nicorandil"
                    },
                    {
                        "drugbank-id": "DB09363",
                        "description": "Indacaterol may decrease the antihypertensive activities of Rauwolfia serpentina root"
                    },
                    {
                        "drugbank-id": "DB09477",
                        "description": "Indacaterol may decrease the antihypertensive activities of Enalaprilat"
                    },
                    {
                        "drugbank-id": "DB11720",
                        "description": "Indacaterol may decrease the antihypertensive activities of Angiotensin 1 7"
                    },
                    {
                        "drugbank-id": "DB11783",
                        "description": "Indacaterol may decrease the antihypertensive activities of Imidapril"
                    },
                    {
                        "drugbank-id": "DB12054",
                        "description": "Indacaterol may decrease the antihypertensive activities of BQ 123"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "Indacaterol may decrease the antihypertensive activities of Ketanserin"
                    },
                    {
                        "drugbank-id": "DB12945",
                        "description": "Indacaterol may decrease the antihypertensive activities of Dihydralazine"
                    },
                    {
                        "drugbank-id": "DB13166",
                        "description": "Indacaterol may decrease the antihypertensive activities of Zofenopril"
                    },
                    {
                        "drugbank-id": "DB13211",
                        "description": "Indacaterol may decrease the antihypertensive activities of Guanoxan"
                    },
                    {
                        "drugbank-id": "DB13312",
                        "description": "Indacaterol may decrease the antihypertensive activities of Delapril"
                    },
                    {
                        "drugbank-id": "DB13374",
                        "description": "Indacaterol may decrease the antihypertensive activities of Vincamine"
                    },
                    {
                        "drugbank-id": "DB13400",
                        "description": "Indacaterol may decrease the antihypertensive activities of Linsidomine"
                    },
                    {
                        "drugbank-id": "DB13410",
                        "description": "Indacaterol may decrease the antihypertensive activities of Guanoxabenz"
                    },
                    {
                        "drugbank-id": "DB13429",
                        "description": "Indacaterol may decrease the antihypertensive activities of Tolonidine"
                    },
                    {
                        "drugbank-id": "DB13435",
                        "description": "Indacaterol may decrease the antihypertensive activities of Endralazine"
                    },
                    {
                        "drugbank-id": "DB13452",
                        "description": "Indacaterol may decrease the antihypertensive activities of Cadralazine"
                    },
                    {
                        "drugbank-id": "DB13575",
                        "description": "Indacaterol may decrease the antihypertensive activities of Bietaserpine"
                    },
                    {
                        "drugbank-id": "DB13604",
                        "description": "Indacaterol may decrease the antihypertensive activities of Guanazodine"
                    },
                    {
                        "drugbank-id": "DB13631",
                        "description": "Indacaterol may decrease the antihypertensive activities of Methoserpidine"
                    },
                    {
                        "drugbank-id": "DB13779",
                        "description": "Indacaterol may decrease the antihypertensive activities of Guanoclor"
                    },
                    {
                        "drugbank-id": "DB13801",
                        "description": "Indacaterol may decrease the antihypertensive activities of Muzolimine"
                    },
                    {
                        "drugbank-id": "DB13803",
                        "description": "Indacaterol may decrease the antihypertensive activities of Xipamide"
                    },
                    {
                        "drugbank-id": "DB14094",
                        "description": "Indacaterol may decrease the antihypertensive activities of Tocopherylquinone"
                    },
                    {
                        "drugbank-id": "DB14125",
                        "description": "Indacaterol may decrease the antihypertensive activities of Benazeprilat"
                    },
                    {
                        "drugbank-id": "DB14207",
                        "description": "Indacaterol may decrease the antihypertensive activities of Fosinoprilat"
                    },
                    {
                        "drugbank-id": "DB14208",
                        "description": "Indacaterol may decrease the antihypertensive activities of Ramiprilat"
                    },
                    {
                        "drugbank-id": "DB14213",
                        "description": "Indacaterol may decrease the antihypertensive activities of Perindoprilat"
                    },
                    {
                        "drugbank-id": "DB14217",
                        "description": "Indacaterol may decrease the antihypertensive activities of Quinaprilat"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "Indacaterol may decrease the antihypertensive activities of Lercanidipine"
                    },
                    {
                        "drugbank-id": "DB00559",
                        "description": "Indacaterol may decrease the antihypertensive activities of Bosentan"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "Indacaterol may decrease the antihypertensive activities of Eplerenone"
                    },
                    {
                        "drugbank-id": "DB00820",
                        "description": "Indacaterol may decrease the antihypertensive activities of Tadalafil"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "Indacaterol may decrease the antihypertensive activities of Guanfacine"
                    },
                    {
                        "drugbank-id": "DB01029",
                        "description": "Indacaterol may decrease the antihypertensive activities of Irbesartan"
                    },
                    {
                        "drugbank-id": "DB01275",
                        "description": "Indacaterol may decrease the antihypertensive activities of Hydralazine"
                    },
                    {
                        "drugbank-id": "DB06268",
                        "description": "Indacaterol may decrease the antihypertensive activities of Sitaxentan"
                    },
                    {
                        "drugbank-id": "DB06762",
                        "description": "Indacaterol may decrease the antihypertensive activities of Pinacidil"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "Indacaterol may decrease the antihypertensive activities of Riociguat"
                    },
                    {
                        "drugbank-id": "DB08932",
                        "description": "Indacaterol may decrease the antihypertensive activities of Macitentan"
                    },
                    {
                        "drugbank-id": "DB09026",
                        "description": "Indacaterol may decrease the antihypertensive activities of Aliskiren"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "Indacaterol may decrease the antihypertensive activities of Manidipine"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "Indacaterol may decrease the antihypertensive activities of Naftopidil"
                    },
                    {
                        "drugbank-id": "DB00381",
                        "description": "Indacaterol may decrease the antihypertensive activities of Amlodipine"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "Indacaterol may decrease the antihypertensive activities of Nisoldipine"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "Indacaterol may decrease the antihypertensive activities of Clonidine"
                    },
                    {
                        "drugbank-id": "DB00584",
                        "description": "Indacaterol may decrease the antihypertensive activities of Enalapril"
                    },
                    {
                        "drugbank-id": "DB00796",
                        "description": "Indacaterol may decrease the antihypertensive activities of Candesartan cilexetil"
                    },
                    {
                        "drugbank-id": "DB00966",
                        "description": "Indacaterol may decrease the antihypertensive activities of Telmisartan"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "Indacaterol may decrease the antihypertensive activities of Captopril"
                    },
                    {
                        "drugbank-id": "DB01340",
                        "description": "Indacaterol may decrease the antihypertensive activities of Cilazapril"
                    },
                    {
                        "drugbank-id": "DB04840",
                        "description": "Indacaterol may decrease the antihypertensive activities of Debrisoquine"
                    },
                    {
                        "drugbank-id": "DB13919",
                        "description": "Indacaterol may decrease the antihypertensive activities of Candesartan"
                    },
                    {
                        "drugbank-id": "DB09237",
                        "description": "Indacaterol may decrease the antihypertensive activities of Levamlodipine"
                    },
                    {
                        "drugbank-id": "DB00035",
                        "description": "The risk or severity of hypertension can be increased when Desmopressin is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00159",
                        "description": "The risk or severity of hypertension can be increased when Icosapent is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The risk or severity of hypertension can be increased when Amphetamine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00211",
                        "description": "The risk or severity of hypertension can be increased when Midodrine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00217",
                        "description": "The risk or severity of hypertension can be increased when Bethanidine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "The risk or severity of hypertension can be increased when Mesalazine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "The risk or severity of hypertension can be increased when Etomidate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00315",
                        "description": "The risk or severity of hypertension can be increased when Zolmitriptan is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00388",
                        "description": "The risk or severity of hypertension can be increased when Phenylephrine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "The risk or severity of hypertension can be increased when Methylphenidate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "The risk or severity of hypertension can be increased when Nabumetone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "The risk or severity of hypertension can be increased when Ketorolac is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "The risk or severity of hypertension can be increased when Tenoxicam is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00500",
                        "description": "The risk or severity of hypertension can be increased when Tolmetin is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "The risk or severity of hypertension can be increased when Piroxicam is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00561",
                        "description": "The risk or severity of hypertension can be increased when Doxapram is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00573",
                        "description": "The risk or severity of hypertension can be increased when Fenoprofen is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00605",
                        "description": "The risk or severity of hypertension can be increased when Sulindac is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00610",
                        "description": "The risk or severity of hypertension can be increased when Metaraminol is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00629",
                        "description": "The risk or severity of hypertension can be increased when Guanabenz is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "The risk or severity of hypertension can be increased when Dexmedetomidine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00723",
                        "description": "The risk or severity of hypertension can be increased when Methoxamine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "The risk or severity of hypertension can be increased when Etodolac is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "The risk or severity of hypertension can be increased when Mefenamic acid is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The risk or severity of hypertension can be increased when Sulfasalazine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00821",
                        "description": "The risk or severity of hypertension can be increased when Carprofen is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00830",
                        "description": "The risk or severity of hypertension can be increased when Phenmetrazine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "The risk or severity of hypertension can be increased when Diflunisal is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00886",
                        "description": "The risk or severity of hypertension can be increased when Omapatrilat is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "The risk or severity of hypertension can be increased when Remifentanil is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00935",
                        "description": "The risk or severity of hypertension can be increased when Oxymetazoline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "The risk or severity of hypertension can be increased when Salicylic acid is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "The risk or severity of hypertension can be increased when Diethylpropion is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00952",
                        "description": "The risk or severity of hypertension can be increased when Naratriptan is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "The risk or severity of hypertension can be increased when Rizatriptan is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "The risk or severity of hypertension can be increased when Dopamine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00991",
                        "description": "The risk or severity of hypertension can be increased when Oxaprozin is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00998",
                        "description": "The risk or severity of hypertension can be increased when Frovatriptan is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "The risk or severity of hypertension can be increased when Ketoprofen is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01014",
                        "description": "The risk or severity of hypertension can be increased when Balsalazide is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01180",
                        "description": "The risk or severity of hypertension can be increased when Rescinnamine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01250",
                        "description": "The risk or severity of hypertension can be increased when Olsalazine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01283",
                        "description": "The risk or severity of hypertension can be increased when Lumiracoxib is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01364",
                        "description": "The risk or severity of hypertension can be increased when Ephedrine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "The risk or severity of hypertension can be increased when Mephentermine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "The risk or severity of hypertension can be increased when Magnesium salicylate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01399",
                        "description": "The risk or severity of hypertension can be increased when Salsalate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01401",
                        "description": "The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01419",
                        "description": "The risk or severity of hypertension can be increased when Antrafenine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "The risk or severity of hypertension can be increased when MMDA is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "The risk or severity of hypertension can be increased when Midomafetamine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "The risk or severity of hypertension can be increased when 2 5 Dimethoxy 4 ethylamphetamine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "The risk or severity of hypertension can be increased when 4 Methoxyamphetamine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "The risk or severity of hypertension can be increased when 4 Bromo 2 5 dimethoxyamphetamine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "The risk or severity of hypertension can be increased when Tenamfetamine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "The risk or severity of hypertension can be increased when Chlorphentermine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "The risk or severity of hypertension can be increased when Dextroamphetamine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "The risk or severity of hypertension can be increased when Metamfetamine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01579",
                        "description": "The risk or severity of hypertension can be increased when Phendimetrazine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01600",
                        "description": "The risk or severity of hypertension can be increased when Tiaprofenic acid is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB02032",
                        "description": "The risk or severity of hypertension can be increased when Epicaptopril is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB02224",
                        "description": "The risk or severity of hypertension can be increased when Taxifolin is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB03585",
                        "description": "The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB04581",
                        "description": "The risk or severity of hypertension can be increased when 1 benzylimidazole is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB04812",
                        "description": "The risk or severity of hypertension can be increased when Benoxaprofen is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB05095",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Cimicoxib"
                    },
                    {
                        "drugbank-id": "DB05395",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Amibegron"
                    },
                    {
                        "drugbank-id": "DB05562",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Naluzotan"
                    },
                    {
                        "drugbank-id": "DB06190",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Solabegron"
                    },
                    {
                        "drugbank-id": "DB06678",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Esmirtazapine"
                    },
                    {
                        "drugbank-id": "DB06690",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Nitrous oxide"
                    },
                    {
                        "drugbank-id": "DB06694",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Xylometazoline"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Dexmethylphenidate"
                    },
                    {
                        "drugbank-id": "DB06706",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Isometheptene"
                    },
                    {
                        "drugbank-id": "DB06707",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Levonordefrin"
                    },
                    {
                        "drugbank-id": "DB06711",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Naphazoline"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Lornoxicam"
                    },
                    {
                        "drugbank-id": "DB06736",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Aceclofenac"
                    },
                    {
                        "drugbank-id": "DB06737",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Zaltoprofen"
                    },
                    {
                        "drugbank-id": "DB06763",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Saralasin"
                    },
                    {
                        "drugbank-id": "DB06764",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Tetryzoline"
                    },
                    {
                        "drugbank-id": "DB07402",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Azapropazone"
                    },
                    {
                        "drugbank-id": "DB08797",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Salicylamide"
                    },
                    {
                        "drugbank-id": "DB08810",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Cinitapride"
                    },
                    {
                        "drugbank-id": "DB08841",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Tyramine"
                    },
                    {
                        "drugbank-id": "DB08925",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Adrafinil"
                    },
                    {
                        "drugbank-id": "DB08940",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Kebuzone"
                    },
                    {
                        "drugbank-id": "DB08941",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Isoxsuprine"
                    },
                    {
                        "drugbank-id": "DB08942",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Isoxicam"
                    },
                    {
                        "drugbank-id": "DB08951",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Indoprofen"
                    },
                    {
                        "drugbank-id": "DB08954",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Ifenprodil"
                    },
                    {
                        "drugbank-id": "DB08955",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Ibuproxam"
                    },
                    {
                        "drugbank-id": "DB08976",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Floctafenine"
                    },
                    {
                        "drugbank-id": "DB08981",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Fenbufen"
                    },
                    {
                        "drugbank-id": "DB08984",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Etofenamate"
                    },
                    {
                        "drugbank-id": "DB08985",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Etilefrine"
                    },
                    {
                        "drugbank-id": "DB08991",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Epirizole"
                    },
                    {
                        "drugbank-id": "DB09084",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Benzydamine"
                    },
                    {
                        "drugbank-id": "DB09202",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Cirazoline"
                    },
                    {
                        "drugbank-id": "DB09203",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Synephrine"
                    },
                    {
                        "drugbank-id": "DB09205",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Moxisylyte"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Dexibuprofen"
                    },
                    {
                        "drugbank-id": "DB09214",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Dexketoprofen"
                    },
                    {
                        "drugbank-id": "DB09215",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Droxicam"
                    },
                    {
                        "drugbank-id": "DB09217",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Firocoxib"
                    },
                    {
                        "drugbank-id": "DB09218",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Clonixin"
                    },
                    {
                        "drugbank-id": "DB09242",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Moxonidine"
                    },
                    {
                        "drugbank-id": "DB09285",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Morniflumate"
                    },
                    {
                        "drugbank-id": "DB09295",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Talniflumate"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Iofetamine I 123"
                    },
                    {
                        "drugbank-id": "DB11278",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with DL Methylephedrine"
                    },
                    {
                        "drugbank-id": "DB11373",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Amitraz"
                    },
                    {
                        "drugbank-id": "DB11428",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Medetomidine"
                    },
                    {
                        "drugbank-id": "DB11455",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Robenacoxib"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Tepoxalin"
                    },
                    {
                        "drugbank-id": "DB11477",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Xylazine"
                    },
                    {
                        "drugbank-id": "DB11481",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Atipamezole"
                    },
                    {
                        "drugbank-id": "DB11518",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Flunixin"
                    },
                    {
                        "drugbank-id": "DB11541",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Ractopamine"
                    },
                    {
                        "drugbank-id": "DB11543",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Romifidine"
                    },
                    {
                        "drugbank-id": "DB11556",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Detomidine"
                    },
                    {
                        "drugbank-id": "DB11738",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Rilmenidine"
                    },
                    {
                        "drugbank-id": "DB11755",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Ritobegron"
                    },
                    {
                        "drugbank-id": "DB12248",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Tulobuterol"
                    },
                    {
                        "drugbank-id": "DB12313",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Dopexamine"
                    },
                    {
                        "drugbank-id": "DB12361",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Piclozotan"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Nitroaspirin"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Indobufen"
                    },
                    {
                        "drugbank-id": "DB12551",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Idazoxan"
                    },
                    {
                        "drugbank-id": "DB12610",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Ebselen"
                    },
                    {
                        "drugbank-id": "DB12779",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Higenamine"
                    },
                    {
                        "drugbank-id": "DB12846",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Reproterol"
                    },
                    {
                        "drugbank-id": "DB13001",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Tinoridine"
                    },
                    {
                        "drugbank-id": "DB13064",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Tramazoline"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Mephedrone"
                    },
                    {
                        "drugbank-id": "DB13167",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Alclofenac"
                    },
                    {
                        "drugbank-id": "DB13217",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Fentiazac"
                    },
                    {
                        "drugbank-id": "DB13232",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Suxibuzone"
                    },
                    {
                        "drugbank-id": "DB13251",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Octopamine"
                    },
                    {
                        "drugbank-id": "DB13286",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Bumadizone"
                    },
                    {
                        "drugbank-id": "DB13314",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Alminoprofen"
                    },
                    {
                        "drugbank-id": "DB13323",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Trichloroethylene"
                    },
                    {
                        "drugbank-id": "DB13341",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Fenozolone"
                    },
                    {
                        "drugbank-id": "DB13371",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Difenpiramide"
                    },
                    {
                        "drugbank-id": "DB13378",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Norfenefrine"
                    },
                    {
                        "drugbank-id": "DB13398",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Oxyfedrine"
                    },
                    {
                        "drugbank-id": "DB13407",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Nifenazone"
                    },
                    {
                        "drugbank-id": "DB13432",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Lonazolac"
                    },
                    {
                        "drugbank-id": "DB13453",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Xenon"
                    },
                    {
                        "drugbank-id": "DB13481",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Tenidap"
                    },
                    {
                        "drugbank-id": "DB13510",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Buflomedil"
                    },
                    {
                        "drugbank-id": "DB13524",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Propyphenazone"
                    },
                    {
                        "drugbank-id": "DB13527",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Proglumetacin"
                    },
                    {
                        "drugbank-id": "DB13538",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Guacetisal"
                    },
                    {
                        "drugbank-id": "DB13544",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Ethenzamide"
                    },
                    {
                        "drugbank-id": "DB13559",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Rimiterol"
                    },
                    {
                        "drugbank-id": "DB13612",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Carbaspirin calcium"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Methoxyphenamine"
                    },
                    {
                        "drugbank-id": "DB13629",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Mofebutazone"
                    },
                    {
                        "drugbank-id": "DB13649",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Proquazone"
                    },
                    {
                        "drugbank-id": "DB13657",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Benorilate"
                    },
                    {
                        "drugbank-id": "DB13692",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Tretoquinol"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Gepefrine"
                    },
                    {
                        "drugbank-id": "DB13722",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Pirprofen"
                    },
                    {
                        "drugbank-id": "DB13777",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Prenalterol"
                    },
                    {
                        "drugbank-id": "DB13781",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Xamoterol"
                    },
                    {
                        "drugbank-id": "DB13783",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Acemetacin"
                    },
                    {
                        "drugbank-id": "DB13852",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Mefenorex"
                    },
                    {
                        "drugbank-id": "DB13860",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Imidazole salicylate"
                    },
                    {
                        "drugbank-id": "DB13917",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Deoxyepinephrine"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with 2 5 Dimethoxy 4 ethylthioamphetamine"
                    },
                    {
                        "drugbank-id": "DB14010",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with 5 methoxy N N dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB14059",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with SC 236"
                    },
                    {
                        "drugbank-id": "DB14060",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with NS 398"
                    },
                    {
                        "drugbank-id": "DB14231",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Quinoline Yellow WS"
                    },
                    {
                        "drugbank-id": "DB01126",
                        "description": "The risk or severity of hypertension can be increased when Dutasteride is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The risk or severity of hypertension can be increased when Phentermine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "The risk or severity of hypertension can be increased when Rofecoxib is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00580",
                        "description": "The risk or severity of hypertension can be increased when Valdecoxib is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "The risk or severity of hypertension can be increased when Sufentanil is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The risk or severity of hypertension can be increased when Tranylcypromine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The risk or severity of hypertension can be increased when Phenelzine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "The risk or severity of hypertension can be increased when Phenylbutazone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "The risk or severity of hypertension can be increased when Meloxicam is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "The risk or severity of hypertension can be increased when Benzphetamine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "The risk or severity of hypertension can be increased when Almotriptan is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01028",
                        "description": "The risk or severity of hypertension can be increased when Methoxyflurane is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01159",
                        "description": "The risk or severity of hypertension can be increased when Halothane is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01216",
                        "description": "The risk or severity of hypertension can be increased when Finasteride is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "The risk or severity of hypertension can be increased when Aminophenazone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The risk or severity of hypertension can be increased when Antipyrine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "The risk or severity of hypertension can be increased when Etoricoxib is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "The risk or severity of hypertension can be increased when Nimesulide is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB04817",
                        "description": "The risk or severity of hypertension can be increased when Metamizole is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Rotigotine"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Cariprazine"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Mianserin"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Nylidrin"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Safinamide"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Vilazodone"
                    },
                    {
                        "drugbank-id": "DB08439",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Parecoxib"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Vortioxetine"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Tolfenamic acid"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Propacetamol"
                    },
                    {
                        "drugbank-id": "DB12371",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Siponimod"
                    },
                    {
                        "drugbank-id": "DB00216",
                        "description": "The risk or severity of hypertension can be increased when Eletriptan is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "The risk or severity of hypertension can be increased when Celecoxib is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "The risk or severity of hypertension can be increased when Buspirone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "The risk or severity of hypertension can be increased when Diclofenac is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "The risk or severity of hypertension can be increased when Sumatriptan is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "The risk or severity of hypertension can be increased when Naproxen is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The risk or severity of hypertension can be increased when Alfentanil is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The risk or severity of hypertension can be increased when Fentanyl is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The risk or severity of hypertension can be increased when Selegiline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "The risk or severity of hypertension can be increased when Ibuprofen is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01392",
                        "description": "The risk or severity of hypertension can be increased when Yohimbine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB04828",
                        "description": "The risk or severity of hypertension can be increased when Zomepirac is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13598",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Diethyl ether"
                    },
                    {
                        "drugbank-id": "DB15685",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Selpercatinib"
                    },
                    {
                        "drugbank-id": "DB09212",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Loxoprofen"
                    },
                    {
                        "drugbank-id": "DB15965",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB00201",
                        "description": "The risk or severity of adverse effects can be increased when Caffeine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00277",
                        "description": "The risk or severity of adverse effects can be increased when Theophylline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00651",
                        "description": "The risk or severity of adverse effects can be increased when Dyphylline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01033",
                        "description": "The risk or severity of adverse effects can be increased when Mercaptopurine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01223",
                        "description": "The risk or severity of adverse effects can be increased when Aminophylline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01303",
                        "description": "The risk or severity of adverse effects can be increased when Oxtriphylline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01412",
                        "description": "The risk or severity of adverse effects can be increased when Theobromine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01482",
                        "description": "The risk or severity of adverse effects can be increased when Fenethylline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01667",
                        "description": "The risk or severity of adverse effects can be increased when 8 azaguanine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01978",
                        "description": "The risk or severity of adverse effects can be increased when 7 9 Dimethylguanine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB02134",
                        "description": "The risk or severity of adverse effects can be increased when Xanthine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB02245",
                        "description": "The risk or severity of adverse effects can be increased when 7 Deazaguanine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB02377",
                        "description": "The risk or severity of adverse effects can be increased when Guanine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB02489",
                        "description": "The risk or severity of adverse effects can be increased when 9 Methylguanine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB02568",
                        "description": "The risk or severity of adverse effects can be increased when Peldesine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB04076",
                        "description": "The risk or severity of adverse effects can be increased when Hypoxanthine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB04356",
                        "description": "The risk or severity of adverse effects can be increased when 9 Deazaguanine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB06479",
                        "description": "The risk or severity of adverse effects can be increased when Propentofylline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB06575",
                        "description": "The risk or severity of adverse effects can be increased when Valomaciclovir is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB07954",
                        "description": "The risk or severity of adverse effects can be increased when 3 isobutyl 1 methyl 7H xanthine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB08844",
                        "description": "The risk or severity of adverse effects can be increased when Uric acid is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB11919",
                        "description": "The risk or severity of adverse effects can be increased when 6 O benzylguanine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB12406",
                        "description": "The risk or severity of adverse effects can be increased when Lisofylline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB12531",
                        "description": "The risk or severity of adverse effects can be increased when Lobucavir is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB12926",
                        "description": "The risk or severity of adverse effects can be increased when Cafedrine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB12927",
                        "description": "The risk or severity of adverse effects can be increased when Theodrenaline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13203",
                        "description": "The risk or severity of adverse effects can be increased when Bamifylline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13449",
                        "description": "The risk or severity of adverse effects can be increased when Proxyphylline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13573",
                        "description": "The risk or severity of adverse effects can be increased when Acefylline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13592",
                        "description": "The risk or severity of adverse effects can be increased when Etamiphylline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13634",
                        "description": "The risk or severity of adverse effects can be increased when Pentifylline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13812",
                        "description": "The risk or severity of adverse effects can be increased when Bufylline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB14018",
                        "description": "The risk or severity of adverse effects can be increased when Bromotheophylline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB14029",
                        "description": "The risk or severity of adverse effects can be increased when Furafylline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB14132",
                        "description": "The risk or severity of adverse effects can be increased when 8 chlorotheophylline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB15122",
                        "description": "The risk or severity of adverse effects can be increased when PCS 499 is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00895",
                        "description": "Indacaterol may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent"
                    },
                    {
                        "drugbank-id": "DB00421",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00180",
                        "description": "The risk or severity of hypokalemia can be increased when Flunisolide is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00394",
                        "description": "The risk or severity of hypokalemia can be increased when Beclomethasone dipropionate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The risk or severity of hypokalemia can be increased when Betamethasone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The risk or severity of hypokalemia can be increased when Fluticasone propionate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00591",
                        "description": "The risk or severity of hypokalemia can be increased when Fluocinolone acetonide is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The risk or severity of hypokalemia can be increased when Triamcinolone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "The risk or severity of hypokalemia can be increased when Prednisone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00687",
                        "description": "The risk or severity of hypokalemia can be increased when Fludrocortisone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00741",
                        "description": "The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00860",
                        "description": "The risk or severity of hypokalemia can be increased when Prednisolone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00959",
                        "description": "The risk or severity of hypokalemia can be increased when Methylprednisolone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01108",
                        "description": "The risk or severity of hypokalemia can be increased when Trilostane is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01285",
                        "description": "The risk or severity of hypokalemia can be increased when Corticotropin is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01380",
                        "description": "The risk or severity of hypokalemia can be increased when Cortisone acetate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01384",
                        "description": "The risk or severity of hypokalemia can be increased when Paramethasone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01410",
                        "description": "The risk or severity of hypokalemia can be increased when Ciclesonide is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB04630",
                        "description": "The risk or severity of hypokalemia can be increased when Aldosterone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB08906",
                        "description": "The risk or severity of hypokalemia can be increased when Fluticasone furoate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB08970",
                        "description": "The risk or severity of hypokalemia can be increased when Fluprednidene is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB09091",
                        "description": "The risk or severity of hypokalemia can be increased when Tixocortol is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB09378",
                        "description": "The risk or severity of hypokalemia can be increased when Fluprednisolone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB09383",
                        "description": "The risk or severity of hypokalemia can be increased when Meprednisone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB11487",
                        "description": "The risk or severity of hypokalemia can be increased when Dexamethasone isonicotinate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB11529",
                        "description": "The risk or severity of hypokalemia can be increased when Melengestrol is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB11921",
                        "description": "The risk or severity of hypokalemia can be increased when Deflazacort is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13003",
                        "description": "The risk or severity of hypokalemia can be increased when Cortivazol is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13208",
                        "description": "The risk or severity of hypokalemia can be increased when Prednylidene is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13223",
                        "description": "The risk or severity of hypokalemia can be increased when Fluocortin is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13491",
                        "description": "The risk or severity of hypokalemia can be increased when Fluperolone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13843",
                        "description": "The risk or severity of hypokalemia can be increased when Cloprednol is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13856",
                        "description": "The risk or severity of hypokalemia can be increased when Fluclorolone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13867",
                        "description": "The risk or severity of hypokalemia can be increased when Fluticasone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB14539",
                        "description": "The risk or severity of hypokalemia can be increased when Hydrocortisone acetate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB14541",
                        "description": "The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB14545",
                        "description": "The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB14631",
                        "description": "The risk or severity of hypokalemia can be increased when Prednisolone phosphate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB14633",
                        "description": "The risk or severity of hypokalemia can be increased when Prednisolone hemisuccinate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB14644",
                        "description": "The risk or severity of hypokalemia can be increased when Methylprednisolone hemisuccinate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB14646",
                        "description": "The risk or severity of hypokalemia can be increased when Prednisone acetate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB14652",
                        "description": "The risk or severity of hypokalemia can be increased when Clocortolone acetate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB14659",
                        "description": "The risk or severity of hypokalemia can be increased when Melengestrol acetate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB14669",
                        "description": "The risk or severity of hypokalemia can be increased when Betamethasone phosphate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB14681",
                        "description": "The risk or severity of hypokalemia can be increased when Cortisone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "The risk or severity of hypokalemia can be increased when Budesonide is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01013",
                        "description": "The risk or severity of hypokalemia can be increased when Clobetasol propionate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01047",
                        "description": "The risk or severity of hypokalemia can be increased when Fluocinonide is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB14540",
                        "description": "The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00547",
                        "description": "The risk or severity of hypokalemia can be increased when Desoximetasone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00764",
                        "description": "The risk or severity of hypokalemia can be increased when Mometasone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB08971",
                        "description": "The risk or severity of hypokalemia can be increased when Fluocortolone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB11750",
                        "description": "The risk or severity of hypokalemia can be increased when Clobetasol is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB15566",
                        "description": "The risk or severity of hypokalemia can be increased when Prednisolone acetate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00324",
                        "description": "The risk or severity of hypokalemia can be increased when Fluorometholone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "The risk or severity of hypokalemia can be increased when Difluocortolone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00304",
                        "description": "The metabolism of Indacaterol can be increased when combined with Desogestrel"
                    },
                    {
                        "drugbank-id": "DB00495",
                        "description": "The metabolism of Indacaterol can be increased when combined with Zidovudine"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The metabolism of Indacaterol can be increased when combined with Lamotrigine"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "The metabolism of Indacaterol can be increased when combined with Ethinylestradiol"
                    },
                    {
                        "drugbank-id": "DB01420",
                        "description": "The metabolism of Indacaterol can be increased when combined with Testosterone propionate"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The metabolism of Indacaterol can be increased when combined with Nelfinavir"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The metabolism of Indacaterol can be increased when combined with Primidone"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The metabolism of Indacaterol can be increased when combined with Phenytoin"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The metabolism of Indacaterol can be increased when combined with Carbamazepine"
                    },
                    {
                        "drugbank-id": "DB01045",
                        "description": "The metabolism of Indacaterol can be increased when combined with Rifampicin"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The metabolism of Indacaterol can be increased when combined with Phenobarbital"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "Atomoxetine may increase the tachycardic activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB09059",
                        "description": "The risk or severity of adverse effects can be increased when Indacaterol is combined with Atosiban"
                    },
                    {
                        "drugbank-id": "DB06698",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Betahistine"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "Cabergoline may increase the hypertensive and vasoconstricting activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00353",
                        "description": "Methylergometrine may increase the hypertensive and vasoconstricting activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "Lisuride may increase the hypertensive and vasoconstricting activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00699",
                        "description": "Nicergoline may increase the hypertensive and vasoconstricting activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01049",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "Pergolide may increase the hypertensive and vasoconstricting activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "Ergometrine may increase the hypertensive and vasoconstricting activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "Lysergic acid diethylamide may increase the hypertensive and vasoconstricting activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB11273",
                        "description": "Dihydroergocornine may increase the hypertensive and vasoconstricting activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13345",
                        "description": "Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13385",
                        "description": "Dihydroergocryptine may increase the hypertensive and vasoconstricting activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13399",
                        "description": "Terguride may increase the hypertensive and vasoconstricting activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13520",
                        "description": "Metergoline may increase the hypertensive and vasoconstricting activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "Indacaterol may increase the hypertensive and vasoconstricting activities of Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "Indacaterol may increase the hypertensive and vasoconstricting activities of Ergotamine"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "Indacaterol may increase the hypertensive and vasoconstricting activities of Bromocriptine"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "Methysergide may increase the hypertensive and vasoconstricting activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "Venlafaxine may increase the tachycardic activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "Duloxetine may increase the tachycardic activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "Sibutramine may increase the tachycardic activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "Milnacipran may increase the tachycardic activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "Desvenlafaxine may increase the tachycardic activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "Levomilnacipran may increase the tachycardic activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "Nefazodone may increase the tachycardic activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB09280",
                        "description": "The serum concentration of Indacaterol can be decreased when it is combined with Lumacaftor"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Olanzapine"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Alfuzosin"
                    },
                    {
                        "drugbank-id": "DB00692",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Phentolamine"
                    },
                    {
                        "drugbank-id": "DB00706",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Tamsulosin"
                    },
                    {
                        "drugbank-id": "DB00777",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Propiomazine"
                    },
                    {
                        "drugbank-id": "DB00797",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Tolazoline"
                    },
                    {
                        "drugbank-id": "DB00925",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Phenoxybenzamine"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Aripiprazole"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Methotrimeprazine"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Periciazine"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Acepromazine"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Thioproperazine"
                    },
                    {
                        "drugbank-id": "DB06153",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Pizotifen"
                    },
                    {
                        "drugbank-id": "DB06207",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Silodosin"
                    },
                    {
                        "drugbank-id": "DB08950",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Indoramin"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Brexpiprazole"
                    },
                    {
                        "drugbank-id": "DB09206",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Trimazosin"
                    },
                    {
                        "drugbank-id": "DB12230",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Bunazosin"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Propiverine"
                    },
                    {
                        "drugbank-id": "DB12661",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Urapidil"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Aripiprazole lauroxil"
                    },
                    {
                        "drugbank-id": "DB00457",
                        "description": "The therapeutic efficacy of Prazosin can be decreased when used in combination with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "The therapeutic efficacy of Doxazosin can be decreased when used in combination with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01162",
                        "description": "The therapeutic efficacy of Terazosin can be decreased when used in combination with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Trifluoperazine"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The risk or severity of hypertension can be increased when Amoxapine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "The risk or severity of hypertension can be increased when Amineptine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "The risk or severity of hypertension can be increased when Dimetacrine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The risk or severity of hypertension can be increased when Dosulepin is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "The risk or severity of hypertension can be increased when Oxaprotiline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "The risk or severity of hypertension can be increased when Opipramol is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "The risk or severity of hypertension can be increased when Amitriptylinoxide is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "The risk or severity of hypertension can be increased when Dibenzepin is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "The risk or severity of hypertension can be increased when Quinupramine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "The risk or severity of hypertension can be increased when Melitracen is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "The risk or severity of hypertension can be increased when Lofepramine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "The risk or severity of hypertension can be increased when Iprindole is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "The risk or severity of hypertension can be increased when Imipramine oxide is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Tianeptine"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "Timolol may decrease the bronchodilatory activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "Sotalol may decrease the bronchodilatory activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "Propranolol may decrease the bronchodilatory activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "Alprenolol may decrease the bronchodilatory activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "Pindolol may decrease the bronchodilatory activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "Nadolol may decrease the bronchodilatory activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "Penbutolol may decrease the bronchodilatory activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "Oxprenolol may decrease the bronchodilatory activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB08807",
                        "description": "Bopindolol may decrease the bronchodilatory activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "Bupranolol may decrease the bronchodilatory activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13508",
                        "description": "Cloranolol may decrease the bronchodilatory activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13530",
                        "description": "Mepindolol may decrease the bronchodilatory activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13775",
                        "description": "Tertatolol may decrease the bronchodilatory activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "Indacaterol may increase the hypokalemic activities of Methyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00310",
                        "description": "Indacaterol may increase the hypokalemic activities of Chlorthalidone"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "Indacaterol may increase the hypokalemic activities of Bendroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00524",
                        "description": "Indacaterol may increase the hypokalemic activities of Metolazone"
                    },
                    {
                        "drugbank-id": "DB00562",
                        "description": "Indacaterol may increase the hypokalemic activities of Benzthiazide"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "Indacaterol may increase the hypokalemic activities of Hydroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "Indacaterol may increase the hypokalemic activities of Chlorothiazide"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "Indacaterol may increase the hypokalemic activities of Trichlormethiazide"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "Indacaterol may increase the hypokalemic activities of Polythiazide"
                    },
                    {
                        "drugbank-id": "DB01325",
                        "description": "Indacaterol may increase the hypokalemic activities of Quinethazone"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "Indacaterol may increase the hypokalemic activities of Cyclopenthiazide"
                    },
                    {
                        "drugbank-id": "DB13989",
                        "description": "Indacaterol may increase the hypokalemic activities of Epitizide"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Leuprolide"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Goserelin"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Moxifloxacin"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Sulfisoxazole"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Clozapine"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Sulpiride"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Promazine"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Prochlorperazine"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Droperidol"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Chlorpromazine"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Oxaliplatin"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB00556",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Perflutren"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Cinnarizine"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Atropine"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Adenosine"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Pentamidine"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Gadobenic acid"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Carbinoxamine"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Dolasetron"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Roxithromycin"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Nalidixic acid"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Cinoxacin"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Granisetron"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Desloratadine"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Lomefloxacin"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Dimenhydrinate"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Papaverine"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Chlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Gemifloxacin"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Ofloxacin"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Flecainide"
                    },
                    {
                        "drugbank-id": "DB01599",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Probucol"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB02638",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Terlipressin"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Prenylamine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Lofexidine"
                    },
                    {
                        "drugbank-id": "DB04957",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Azimilide"
                    },
                    {
                        "drugbank-id": "DB05223",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Pracinostat"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Technetium Tc 99m ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Garenoxacin"
                    },
                    {
                        "drugbank-id": "DB06200",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Tedisamil"
                    },
                    {
                        "drugbank-id": "DB06334",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Tucidinostat"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Telavancin"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Nemonoxacin"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Panobinostat"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB08799",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Antazoline"
                    },
                    {
                        "drugbank-id": "DB08903",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Bedaquiline"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Fendiline"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Eperisone"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Ceritinib"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Lenvatinib"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Melperone"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Benidipine"
                    },
                    {
                        "drugbank-id": "DB09555",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11640",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11830",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Mocetinostat"
                    },
                    {
                        "drugbank-id": "DB11841",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Entinostat"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB12174",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with CUDC 101"
                    },
                    {
                        "drugbank-id": "DB12286",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Simendan"
                    },
                    {
                        "drugbank-id": "DB12376",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Ricolinostat"
                    },
                    {
                        "drugbank-id": "DB12523",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Mizolastine"
                    },
                    {
                        "drugbank-id": "DB12565",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Abexinostat"
                    },
                    {
                        "drugbank-id": "DB12877",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Oxatomide"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Sitafloxacin"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Otilonium"
                    },
                    {
                        "drugbank-id": "DB13546",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Nizofenone"
                    },
                    {
                        "drugbank-id": "DB13652",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Bunaftine"
                    },
                    {
                        "drugbank-id": "DB13653",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Lorcainide"
                    },
                    {
                        "drugbank-id": "DB13679",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Dexchlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Penfluridol"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Efavirenz"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Telithromycin"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Levacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Diltiazem"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Nimodipine"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The risk or severity of QTc prolongation can be increased when Amitriptyline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The risk or severity of QTc prolongation can be increased when Imipramine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Azithromycin"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Methadone"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Chloroquine"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Primaquine"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Nifedipine"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Levofloxacin"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Dexverapamil"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Encorafenib"
                    },
                    {
                        "drugbank-id": "DB01084",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Emedastine"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Citalopram"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Clemastine"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Ibutilide"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Grepafloxacin"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Quinine"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Erlotinib"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Thioridazine"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Trovafloxacin"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Flupentixol"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Cocaine"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Procainamide"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Domperidone"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Sparfloxacin"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Bepridil"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Temafloxacin"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB04844",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Tetrabenazine"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Iloperidone"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Romidepsin"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB06697",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Artemether"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Lumefantrine"
                    },
                    {
                        "drugbank-id": "DB09083",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Ivabradine"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Ribociclib"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Deutetrabenazine"
                    },
                    {
                        "drugbank-id": "DB13074",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Macimorelin"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Terodiline"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Dofetilide"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Cisapride"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Terfenadine"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Astemizole"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Pimozide"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "The risk or severity of hypokalemia can be increased when Indacaterol is combined with Torasemide"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "The risk or severity of hypokalemia can be increased when Indacaterol is combined with Furosemide"
                    },
                    {
                        "drugbank-id": "DB00887",
                        "description": "The risk or severity of hypokalemia can be increased when Indacaterol is combined with Bumetanide"
                    },
                    {
                        "drugbank-id": "DB00903",
                        "description": "The risk or severity of hypokalemia can be increased when Indacaterol is combined with Etacrynic acid"
                    },
                    {
                        "drugbank-id": "DB02925",
                        "description": "The risk or severity of hypokalemia can be increased when Indacaterol is combined with Piretanide"
                    },
                    {
                        "drugbank-id": "DB08961",
                        "description": "The risk or severity of hypokalemia can be increased when Indacaterol is combined with Azosemide"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of adverse effects can be increased when Linezolid is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "The risk or severity of adverse effects can be increased when Furazolidone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "The risk or severity of adverse effects can be increased when Procaine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The risk or severity of adverse effects can be increased when Minaprine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of adverse effects can be increased when Procarbazine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The risk or severity of adverse effects can be increased when Moclobemide is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "The risk or severity of adverse effects can be increased when Rasagiline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "The risk or severity of adverse effects can be increased when Pargyline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "The risk or severity of adverse effects can be increased when Clorgiline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The risk or severity of adverse effects can be increased when Iproniazid is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "The risk or severity of adverse effects can be increased when Nialamide is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "The risk or severity of adverse effects can be increased when 7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "The risk or severity of adverse effects can be increased when Hydracarbazine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "The risk or severity of adverse effects can be increased when Pirlindole is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "The risk or severity of adverse effects can be increased when Toloxatone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "The risk or severity of adverse effects can be increased when Benmoxin is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "The risk or severity of adverse effects can be increased when Mebanazine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "The risk or severity of adverse effects can be increased when Octamoxin is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "The risk or severity of adverse effects can be increased when Pheniprazine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "The risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "The risk or severity of adverse effects can be increased when Pivhydrazine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "The risk or severity of adverse effects can be increased when Safrazine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "The risk or severity of adverse effects can be increased when Caroxazone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "The risk or severity of adverse effects can be increased when Harmaline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "The risk or severity of adverse effects can be increased when Brofaromine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00221",
                        "description": "The risk or severity of adverse effects can be increased when Isoetharine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00368",
                        "description": "The risk or severity of adverse effects can be increased when Norepinephrine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00397",
                        "description": "The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "The risk or severity of adverse effects can be increased when Epinephrine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00816",
                        "description": "The risk or severity of adverse effects can be increased when Orciprenaline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00841",
                        "description": "The risk or severity of adverse effects can be increased when Dobutamine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00867",
                        "description": "The risk or severity of adverse effects can be increased when Ritodrine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of adverse effects can be increased when Terbutaline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00901",
                        "description": "The risk or severity of adverse effects can be increased when Bitolterol is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of adverse effects can be increased when Salmeterol is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of adverse effects can be increased when Salbutamol is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01064",
                        "description": "The risk or severity of adverse effects can be increased when Isoprenaline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01102",
                        "description": "The risk or severity of adverse effects can be increased when Arbutamine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The risk or severity of adverse effects can be increased when Arformoterol is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01288",
                        "description": "The risk or severity of adverse effects can be increased when Fenoterol is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01291",
                        "description": "The risk or severity of adverse effects can be increased when Pirbuterol is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01363",
                        "description": "The risk or severity of adverse effects can be increased when Ephedra sinica root is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01366",
                        "description": "The risk or severity of adverse effects can be increased when Procaterol is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01407",
                        "description": "The risk or severity of adverse effects can be increased when Clenbuterol is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01408",
                        "description": "The risk or severity of adverse effects can be increased when Bambuterol is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB06262",
                        "description": "The risk or severity of adverse effects can be increased when Indacaterol is combined with Droxidopa"
                    },
                    {
                        "drugbank-id": "DB06814",
                        "description": "The risk or severity of adverse effects can be increased when Indacaterol is combined with Protokylol"
                    },
                    {
                        "drugbank-id": "DB08957",
                        "description": "The risk or severity of adverse effects can be increased when Indacaterol is combined with Hexoprenaline"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of adverse effects can be increased when Indacaterol is combined with Olodaterol"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of adverse effects can be increased when Indacaterol is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB11124",
                        "description": "The risk or severity of adverse effects can be increased when Indacaterol is combined with Racepinephrine"
                    },
                    {
                        "drugbank-id": "DB11587",
                        "description": "The risk or severity of adverse effects can be increased when Indacaterol is combined with Etafedrine"
                    },
                    {
                        "drugbank-id": "DB11871",
                        "description": "The risk or severity of adverse effects can be increased when Indacaterol is combined with PF 00610355"
                    },
                    {
                        "drugbank-id": "DB12100",
                        "description": "The risk or severity of adverse effects can be increased when Indacaterol is combined with Abediterol"
                    },
                    {
                        "drugbank-id": "DB12526",
                        "description": "The risk or severity of adverse effects can be increased when Indacaterol is combined with Batefenterol"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "The risk or severity of adverse effects can be increased when Indacaterol is combined with Levosalbutamol"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB09273",
                        "description": "The risk or severity of adverse effects can be increased when Doxofylline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "The serum concentration of Indacaterol can be decreased when it is combined with Apalutamide"
                    },
                    {
                        "drugbank-id": "DB11637",
                        "description": "Indacaterol may increase the QTc prolonging activities of Delamanid"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The serum concentration of Indacaterol can be decreased when it is combined with Pitolisant"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Isavuconazole"
                    },
                    {
                        "drugbank-id": "DB06636",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Isavuconazonium"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Methylene blue"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Fluconazole"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Reserpine"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Verapamil"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Tamoxifen"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Zonisamide"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Mibefradil"
                    },
                    {
                        "drugbank-id": "DB04851",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Biricodar"
                    },
                    {
                        "drugbank-id": "DB04881",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Elacridar"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Flibanserin"
                    },
                    {
                        "drugbank-id": "DB06191",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Zosuquidar"
                    },
                    {
                        "drugbank-id": "DB06240",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Tariquidar"
                    },
                    {
                        "drugbank-id": "DB06290",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Simeprevir"
                    },
                    {
                        "drugbank-id": "DB07348",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Brefeldin A"
                    },
                    {
                        "drugbank-id": "DB08820",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Ivacaftor"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB08882",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Linagliptin"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Ponatinib"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08916",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Afatinib"
                    },
                    {
                        "drugbank-id": "DB09027",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Ledipasvir"
                    },
                    {
                        "drugbank-id": "DB09030",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Vorapaxar"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Suvorexant"
                    },
                    {
                        "drugbank-id": "DB09048",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Netupitant"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Palbociclib"
                    },
                    {
                        "drugbank-id": "DB09102",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Daclatasvir"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Niguldipine"
                    },
                    {
                        "drugbank-id": "DB09291",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Rolapitant"
                    },
                    {
                        "drugbank-id": "DB11581",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Venetoclax"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Asunaprevir"
                    },
                    {
                        "drugbank-id": "DB11613",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Velpatasvir"
                    },
                    {
                        "drugbank-id": "DB11828",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Neratinib"
                    },
                    {
                        "drugbank-id": "DB11869",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Valspodar"
                    },
                    {
                        "drugbank-id": "DB12026",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Voxilaprevir"
                    },
                    {
                        "drugbank-id": "DB12035",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Sarecycline"
                    },
                    {
                        "drugbank-id": "DB12799",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Laniquidar"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Dexniguldipine"
                    },
                    {
                        "drugbank-id": "DB14069",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with ONT 093"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Ivosidenib"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "The serum concentration of Conivaptan can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The serum concentration of Tipranavir can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The serum concentration of Amiodarone can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The serum concentration of Lopinavir can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The serum concentration of Dronedarone can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB08827",
                        "description": "The serum concentration of Lomitapide can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB12500",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Fedratinib"
                    },
                    {
                        "drugbank-id": "DB11757",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Istradefylline"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Ketoconazole"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Itraconazole"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB05521",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Telaprevir"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Enzalutamide"
                    },
                    {
                        "drugbank-id": "DB09065",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Cobicistat"
                    },
                    {
                        "drugbank-id": "DB11753",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Rifamycin"
                    },
                    {
                        "drugbank-id": "DB00957",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Norgestimate"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Tacrolimus"
                    },
                    {
                        "drugbank-id": "DB08889",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Carfilzomib"
                    },
                    {
                        "drugbank-id": "DB12466",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Favipiravir"
                    },
                    {
                        "drugbank-id": "DB14840",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Ripretinib"
                    },
                    {
                        "drugbank-id": "DB15822",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Pralsetinib"
                    },
                    {
                        "drugbank-id": "DB06448",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Lonafarnib"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Esmolol"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Betaxolol"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Metoprolol"
                    },
                    {
                        "drugbank-id": "DB00335",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Atenolol"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Labetalol"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Bisoprolol"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Carvedilol"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Propafenone"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Acebutolol"
                    },
                    {
                        "drugbank-id": "DB01295",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Bevantolol"
                    },
                    {
                        "drugbank-id": "DB01297",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Practolol"
                    },
                    {
                        "drugbank-id": "DB03322",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Dexpropranolol"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Celiprolol"
                    },
                    {
                        "drugbank-id": "DB04861",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Nebivolol"
                    },
                    {
                        "drugbank-id": "DB06726",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Bufuralol"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Indenolol"
                    },
                    {
                        "drugbank-id": "DB09204",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Arotinolol"
                    },
                    {
                        "drugbank-id": "DB09351",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Levobetaxolol"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Talinolol"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Anisodamine"
                    },
                    {
                        "drugbank-id": "DB12752",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Bucindolol"
                    },
                    {
                        "drugbank-id": "DB13443",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Esatenolol"
                    },
                    {
                        "drugbank-id": "DB13757",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Epanolol"
                    },
                    {
                        "drugbank-id": "DB12212",
                        "description": "The therapeutic efficacy of Landiolol can be decreased when used in combination with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Hydrochlorothiazide"
                    },
                    {
                        "drugbank-id": "DB00107",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The risk or severity of QTc prolongation can be increased when Buclizine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of QTc prolongation can be increased when Moricizine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of QTc prolongation can be increased when Moexipril is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of QTc prolongation can be increased when Amantadine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00920",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The risk or severity of QTc prolongation can be increased when Famotidine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of QTc prolongation can be increased when Desflurane is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01228",
                        "description": "The risk or severity of QTc prolongation can be increased when Encainide is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01426",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01620",
                        "description": "The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB04695",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Methsuximide"
                    },
                    {
                        "drugbank-id": "DB05465",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Tandutinib"
                    },
                    {
                        "drugbank-id": "DB06217",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Amisulpride"
                    },
                    {
                        "drugbank-id": "DB06468",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Cariporide"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Pasireotide"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06699",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Degarelix"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Buserelin"
                    },
                    {
                        "drugbank-id": "DB06788",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Histrelin"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Triptorelin"
                    },
                    {
                        "drugbank-id": "DB07780",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Farnesyl diphosphate"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Geranylgeranyl diphosphate"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Eribulin"
                    },
                    {
                        "drugbank-id": "DB08936",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Chlorcyclizine"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Flumequine"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Coumaphos"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Dichlorvos"
                    },
                    {
                        "drugbank-id": "DB11408",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Famphur"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Fenthion"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Orbifloxacin"
                    },
                    {
                        "drugbank-id": "DB11448",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Phosmet"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Sarafloxacin"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Difloxacin"
                    },
                    {
                        "drugbank-id": "DB11591",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Bilastine"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Pazufloxacin"
                    },
                    {
                        "drugbank-id": "DB11891",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with CUDC 907"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Prulifloxacin"
                    },
                    {
                        "drugbank-id": "DB12231",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Temefos"
                    },
                    {
                        "drugbank-id": "DB12645",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Givinostat"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Pilsicainide"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Cicletanine"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Cibenzoline"
                    },
                    {
                        "drugbank-id": "DB13555",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Prajmaline"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Oxolinic acid"
                    },
                    {
                        "drugbank-id": "DB13651",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Lorajmine"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Acetyldigoxin"
                    },
                    {
                        "drugbank-id": "DB13744",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Piromidic acid"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Rufloxacin"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Pipemidic acid"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Inotersen"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00719",
                        "description": "The risk or severity of QTc prolongation can be increased when Azatadine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Indapamide"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Efonidipine"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Lacidipine"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "The risk or severity of QTc prolongation can be increased when Galantamine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "The risk or severity of QTc prolongation can be increased when Levomenthol is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of QTc prolongation can be increased when Felbamate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Levocetirizine"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Lurasidone"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Trimebutine"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Pinaverium"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Aranidipine"
                    },
                    {
                        "drugbank-id": "DB11614",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Rupatadine"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Ebastine"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Delafloxacin"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Triclabendazole"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Bencyclane"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Lidoflazine"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Isradipine"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Nicardipine"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Losartan"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Felodipine"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Nitrendipine"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The risk or severity of QTc prolongation can be increased when Nortriptyline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimipramine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of QTc prolongation can be increased when Risperidone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxepin is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The risk or severity of QTc prolongation can be increased when Desipramine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The risk or severity of QTc prolongation can be increased when Octreotide is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The risk or severity of QTc prolongation can be increased when Promethazine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Rilpivirine"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Gallopamil"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB11853",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB09046",
                        "description": "The metabolism of Indacaterol can be increased when combined with Metreleptin"
                    },
                    {
                        "drugbank-id": "DB00173",
                        "description": "The metabolism of Indacaterol can be decreased when combined with Adenine"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The metabolism of Indacaterol can be decreased when combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "The metabolism of Indacaterol can be decreased when combined with Flurbiprofen"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The metabolism of Indacaterol can be decreased when combined with Propofol"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "The metabolism of Indacaterol can be decreased when combined with Probenecid"
                    },
                    {
                        "drugbank-id": "DB01241",
                        "description": "The metabolism of Indacaterol can be decreased when combined with Gemfibrozil"
                    },
                    {
                        "drugbank-id": "DB01544",
                        "description": "The metabolism of Indacaterol can be decreased when combined with Flunitrazepam"
                    },
                    {
                        "drugbank-id": "DB01609",
                        "description": "The metabolism of Indacaterol can be decreased when combined with Deferasirox"
                    },
                    {
                        "drugbank-id": "DB06210",
                        "description": "The metabolism of Indacaterol can be decreased when combined with Eltrombopag"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The metabolism of Indacaterol can be decreased when combined with Pazopanib"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "The metabolism of Indacaterol can be decreased when combined with Regorafenib"
                    },
                    {
                        "drugbank-id": "DB09183",
                        "description": "The metabolism of Indacaterol can be decreased when combined with Dasabuvir"
                    },
                    {
                        "drugbank-id": "DB09276",
                        "description": "The metabolism of Indacaterol can be decreased when combined with Sodium aurothiomalate"
                    },
                    {
                        "drugbank-id": "DB09296",
                        "description": "The metabolism of Indacaterol can be decreased when combined with Ombitasvir"
                    },
                    {
                        "drugbank-id": "DB09297",
                        "description": "The metabolism of Indacaterol can be decreased when combined with Paritaprevir"
                    },
                    {
                        "drugbank-id": "DB09298",
                        "description": "The metabolism of Indacaterol can be decreased when combined with Silibinin"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "The metabolism of Indacaterol can be decreased when combined with Ertugliflozin"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The metabolism of Indacaterol can be decreased when combined with Dacomitinib"
                    },
                    {
                        "drugbank-id": "DB12010",
                        "description": "The metabolism of Indacaterol can be decreased when combined with Fostamatinib"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "The metabolism of Indacaterol can be decreased when combined with Rucaparib"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The metabolism of Indacaterol can be decreased when combined with Enasidenib"
                    },
                    {
                        "drugbank-id": "DB13878",
                        "description": "The metabolism of Indacaterol can be decreased when combined with Pibrentasvir"
                    },
                    {
                        "drugbank-id": "DB13879",
                        "description": "The metabolism of Indacaterol can be decreased when combined with Glecaprevir"
                    },
                    {
                        "drugbank-id": "DB12978",
                        "description": "The metabolism of Indacaterol can be decreased when combined with Pexidartinib"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The metabolism of Indacaterol can be decreased when combined with Indomethacin"
                    },
                    {
                        "drugbank-id": "DB00224",
                        "description": "The metabolism of Indacaterol can be decreased when combined with Indinavir"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The serum concentration of Digitoxin can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The serum concentration of Digoxin can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The serum concentration of Vincristine can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "The serum concentration of Topotecan can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The serum concentration of Bosutinib can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB06769",
                        "description": "The serum concentration of Bendamustine can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB08870",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB11967",
                        "description": "The serum concentration of Binimetinib can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "The serum concentration of Gemcitabine can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB06626",
                        "description": "The serum concentration of Axitinib can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB12001",
                        "description": "The serum concentration of Abemaciclib can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00226",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Guanadrel"
                    },
                    {
                        "drugbank-id": "DB00392",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Profenamine"
                    },
                    {
                        "drugbank-id": "DB12057",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with ORM 12741"
                    },
                    {
                        "drugbank-id": "DB01170",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Guanethidine"
                    },
                    {
                        "drugbank-id": "DB00209",
                        "description": "The risk or severity of Tachycardia can be increased when Trospium is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00219",
                        "description": "The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00332",
                        "description": "The risk or severity of Tachycardia can be increased when Ipratropium is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00340",
                        "description": "The risk or severity of Tachycardia can be increased when Metixene is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00376",
                        "description": "The risk or severity of Tachycardia can be increased when Trihexyphenidyl is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00383",
                        "description": "The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00387",
                        "description": "The risk or severity of Tachycardia can be increased when Procyclidine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00462",
                        "description": "The risk or severity of Tachycardia can be increased when Methscopolamine bromide is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00483",
                        "description": "The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "The risk or severity of Tachycardia can be increased when Nabilone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00505",
                        "description": "The risk or severity of Tachycardia can be increased when Tridihexethyl is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00517",
                        "description": "The risk or severity of Tachycardia can be increased when Anisotropine methylbromide is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00670",
                        "description": "The risk or severity of Tachycardia can be increased when Pirenzepine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00725",
                        "description": "The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00728",
                        "description": "The risk or severity of Tachycardia can be increased when Rocuronium is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00771",
                        "description": "The risk or severity of Tachycardia can be increased when Clidinium is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00782",
                        "description": "The risk or severity of Tachycardia can be increased when Propantheline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00804",
                        "description": "The risk or severity of Tachycardia can be increased when Dicyclomine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00810",
                        "description": "The risk or severity of Tachycardia can be increased when Biperiden is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00940",
                        "description": "The risk or severity of Tachycardia can be increased when Methantheline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00942",
                        "description": "The risk or severity of Tachycardia can be increased when Cycrimine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01148",
                        "description": "The risk or severity of Tachycardia can be increased when Flavoxate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01226",
                        "description": "The risk or severity of Tachycardia can be increased when Mivacurium is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01231",
                        "description": "The risk or severity of Tachycardia can be increased when Diphenidol is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01336",
                        "description": "The risk or severity of Tachycardia can be increased when Metocurine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "The risk or severity of Tachycardia can be increased when Pancuronium is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01338",
                        "description": "The risk or severity of Tachycardia can be increased when Pipecuronium is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01625",
                        "description": "The risk or severity of Tachycardia can be increased when Isopropamide is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB04834",
                        "description": "The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB04843",
                        "description": "The risk or severity of Tachycardia can be increased when Mepenzolate is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB05077",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with SLV319"
                    },
                    {
                        "drugbank-id": "DB06787",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Hexocyclium"
                    },
                    {
                        "drugbank-id": "DB08801",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Dimetindene"
                    },
                    {
                        "drugbank-id": "DB08897",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Aclidinium"
                    },
                    {
                        "drugbank-id": "DB08997",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Dexetimide"
                    },
                    {
                        "drugbank-id": "DB09023",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Benactyzine"
                    },
                    {
                        "drugbank-id": "DB09300",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Butylscopolamine"
                    },
                    {
                        "drugbank-id": "DB11235",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Thonzylamine"
                    },
                    {
                        "drugbank-id": "DB11315",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Methscopolamine"
                    },
                    {
                        "drugbank-id": "DB11903",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with GW842166"
                    },
                    {
                        "drugbank-id": "DB12086",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Oxitropium"
                    },
                    {
                        "drugbank-id": "DB12193",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Ajulemic acid"
                    },
                    {
                        "drugbank-id": "DB12554",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Mebeverine"
                    },
                    {
                        "drugbank-id": "DB12649",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Ibipinabant"
                    },
                    {
                        "drugbank-id": "DB13070",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Surinabant"
                    },
                    {
                        "drugbank-id": "DB13252",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Tropatepine"
                    },
                    {
                        "drugbank-id": "DB13254",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Prifinium"
                    },
                    {
                        "drugbank-id": "DB13351",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Piperidolate"
                    },
                    {
                        "drugbank-id": "DB13369",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Benzilone"
                    },
                    {
                        "drugbank-id": "DB13380",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Difemerine"
                    },
                    {
                        "drugbank-id": "DB13413",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Phenglutarimide"
                    },
                    {
                        "drugbank-id": "DB13448",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Mazaticol"
                    },
                    {
                        "drugbank-id": "DB13468",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Etybenzatropine"
                    },
                    {
                        "drugbank-id": "DB13505",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Emepronium"
                    },
                    {
                        "drugbank-id": "DB13507",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Poldine"
                    },
                    {
                        "drugbank-id": "DB13542",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Bevonium"
                    },
                    {
                        "drugbank-id": "DB13581",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Rociverine"
                    },
                    {
                        "drugbank-id": "DB13619",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Bornaprine"
                    },
                    {
                        "drugbank-id": "DB13636",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Etanautine"
                    },
                    {
                        "drugbank-id": "DB13666",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Tiemonium iodide"
                    },
                    {
                        "drugbank-id": "DB13678",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Dihexyverine"
                    },
                    {
                        "drugbank-id": "DB13695",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Penthienate"
                    },
                    {
                        "drugbank-id": "DB13720",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Diphemanil"
                    },
                    {
                        "drugbank-id": "DB13738",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Camylofin"
                    },
                    {
                        "drugbank-id": "DB13759",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Fenpiverinium"
                    },
                    {
                        "drugbank-id": "DB13769",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Emetonium iodide"
                    },
                    {
                        "drugbank-id": "DB13844",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Pipenzolate"
                    },
                    {
                        "drugbank-id": "DB13850",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Timepidium"
                    },
                    {
                        "drugbank-id": "DB14043",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Palmidrol"
                    },
                    {
                        "drugbank-id": "DB00184",
                        "description": "The risk or severity of Tachycardia can be increased when Nicotine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00496",
                        "description": "The risk or severity of Tachycardia can be increased when Darifenacin is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "The risk or severity of Tachycardia can be increased when Ketamine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "The risk or severity of Tachycardia can be increased when Tiotropium is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB06155",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Rimonabant"
                    },
                    {
                        "drugbank-id": "DB09262",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Imidafenacin"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with WIN 55212 2"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Medical Cannabis"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Nabiximols"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The risk or severity of Tachycardia can be increased when Tramadol is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00470",
                        "description": "The risk or severity of Tachycardia can be increased when Dronabinol is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "The risk or severity of Tachycardia can be increased when Triflupromazine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The risk or severity of Tachycardia can be increased when Paroxetine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00747",
                        "description": "The risk or severity of Tachycardia can be increased when Scopolamine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00767",
                        "description": "The risk or severity of Tachycardia can be increased when Benzquinamide is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Fesoterodine"
                    },
                    {
                        "drugbank-id": "DB09007",
                        "description": "The risk or severity of Tachycardia can be increased when Indacaterol is combined with Chlorphenoxamine"
                    },
                    {
                        "drugbank-id": "DB00175",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Pravastatin"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Morphine"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Clobazam"
                    },
                    {
                        "drugbank-id": "DB00742",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Mannitol"
                    },
                    {
                        "drugbank-id": "DB00882",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Clomifene"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Tegaserod"
                    },
                    {
                        "drugbank-id": "DB01261",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Sitagliptin"
                    },
                    {
                        "drugbank-id": "DB05015",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Belinostat"
                    },
                    {
                        "drugbank-id": "DB05239",
                        "description": "The serum concentration of Cobimetinib can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The serum concentration of Trastuzumab emtansine can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB05889",
                        "description": "The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB06403",
                        "description": "The serum concentration of Ambrisentan can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB06605",
                        "description": "The serum concentration of Apixaban can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB06670",
                        "description": "The serum concentration of Odanacatib can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "The serum concentration of Dabigatran etexilate can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The serum concentration of Dabrafenib can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB08930",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB08934",
                        "description": "The serum concentration of Sofosbuvir can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "The serum concentration of Edoxaban can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "The serum concentration of Umeclidinium can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB09079",
                        "description": "The serum concentration of Nintedanib can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB09161",
                        "description": "The serum concentration of Technetium Tc 99m sestamibi can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB09330",
                        "description": "The serum concentration of Osimertinib can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB11362",
                        "description": "The serum concentration of Selexipag can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB11574",
                        "description": "The serum concentration of Elbasvir can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB11575",
                        "description": "The serum concentration of Grazoprevir can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB11641",
                        "description": "The serum concentration of Vinflunine can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB11760",
                        "description": "The serum concentration of Talazoparib can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "The serum concentration of Baricitinib can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "The serum concentration of Revefenacin can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB11952",
                        "description": "The serum concentration of Duvelisib can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB11979",
                        "description": "The serum concentration of Elagolix can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB11995",
                        "description": "The serum concentration of Avatrombopag can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB12364",
                        "description": "The serum concentration of Betrixaban can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB12455",
                        "description": "The serum concentration of Omadacycline can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB12483",
                        "description": "The serum concentration of Copanlisib can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB12836",
                        "description": "The serum concentration of Grapiprant can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB14126",
                        "description": "The serum concentration of Tenofovir can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB14723",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The serum concentration of Cyclosporine can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The serum concentration of Sildenafil can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The serum concentration of Simvastatin can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The serum concentration of Vardenafil can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The serum concentration of Sirolimus can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The serum concentration of Quinidine can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The serum concentration of Saquinavir can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The serum concentration of Dasatinib can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "The serum concentration of Tolvaptan can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The serum concentration of Temsirolimus can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The serum concentration of Ticagrelor can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Colchicine"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "The serum concentration of Rivaroxaban can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00950",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Fexofenadine"
                    },
                    {
                        "drugbank-id": "DB13007",
                        "description": "The serum concentration of Enfortumab vedotin can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB12941",
                        "description": "The serum concentration of Darolutamide can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB15328",
                        "description": "The serum concentration of Ubrogepant can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB12887",
                        "description": "The serum concentration of Tazemetostat can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Vinblastine"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Etoposide"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Loperamide"
                    },
                    {
                        "drugbank-id": "DB00970",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Dactinomycin"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The serum concentration of Cabazitaxel can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB09054",
                        "description": "The serum concentration of Idelalisib can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB11712",
                        "description": "The serum concentration of Tezacaftor can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB11951",
                        "description": "The serum concentration of Lemborexant can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00300",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Tenofovir disoproxil"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Everolimus"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The serum concentration of Eliglustat can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13125",
                        "description": "The serum concentration of Lusutrombopag can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB12457",
                        "description": "The serum concentration of Rimegepant can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB11689",
                        "description": "The serum concentration of Selumetinib can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB14761",
                        "description": "The serum concentration of Remdesivir can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The serum concentration of Berotralstat can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB15719",
                        "description": "The serum concentration of Belantamab mafodotin can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB11823",
                        "description": "The risk or severity of hypertension can be increased when Esketamine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "The risk or severity of hypertension can be increased when Solriamfetol is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "Testosterone undecanoate may increase the hypertensive activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB12147",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Erdafitinib"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of QTc prolongation can be increased when Trazodone is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "Lefamulin may increase the QTc prolonging activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Lasmiditan"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The serum concentration of Indacaterol can be decreased when it is combined with Cenobamate"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "Formoterol may increase the sympathomimetic activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Ziprasidone"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "The serum concentration of Magnesium can be decreased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Haloperidol"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "Indacaterol may decrease the excretion rate of Tucatinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Indacaterol can be decreased when it is combined with Satralizumab"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}